iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Jones Financial Companies Lllp

Jones Financial Companies Lllp boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 68.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,521 shares of the financial services provider’s stock after purchasing an additional 7,089 shares during the period. Jones Financial Companies Lllp’s holdings in iShares Biotechnology ETF were worth $2,316,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $29,000. HHM Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at $32,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth $36,000. Finally, Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth $33,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of IBB opened at $136.79 on Thursday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The company has a 50-day simple moving average of $135.93 and a 200-day simple moving average of $140.46. The company has a market capitalization of $6.46 billion, a PE ratio of 24.52 and a beta of 0.84.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.